McGrath Yvonne
Insider CIK 1816213 · ITOS VP, Research and Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 91,000 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 69,069 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | D To issuer deriv | 2025-08-29 | 2025-08-29 | 16,054 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | U Tender | 2025-08-29 | 2025-08-29 | 46,300 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 91,000 | — | $0 | 91,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2025-03-07 | 2025-03-11 | 15,300 | — | $0 | 46,300 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2024-03-07 | 2024-03-08 | 153,600 | — | $0 | 153,600 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2023-12-05 | 2023-12-07 | 31,000 | — | $0 | 31,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-03-09 | 2023-03-10 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-03-11 | 2022-03-14 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-02 | 10,000 | — | $0 | 85,123 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-02 | 10,000 | $4.24 | $42.4K | 10,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 10,000 | $36.76 | $367.6K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-06-08 | 2021-06-10 | 7,927 | — | $0 | 95,123 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-06-08 | 2021-06-10 | 7,927 | $20.00 | $158.5K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-06-08 | 2021-06-10 | 7,927 | $4.23 | $33.5K | 7,927 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-06-02 | 2021-06-03 | 323 | — | $0 | 103,050 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-06-02 | 2021-06-03 | 323 | $4.23 | $1.4K | 323 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-03 | 323 | $20.00 | $6.5K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-03 | 7,604 | — | $0 | 103,373 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-03 | 7,604 | $20.18 | $153.4K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-06-01 | 2021-06-03 | 7,604 | $4.23 | $32.2K | 7,604 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-05-24 | 2021-05-26 | 7,927 | — | $0 | 110,977 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-05-24 | 2021-06-03 | 7,927 | — | $0 | 110,977 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-05-24 | 2021-05-26 | 7,927 | $21.92 | $173.8K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-05-24 | 2021-05-26 | 7,927 | $4.23 | $33.5K | 7,927 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-05-24 | 2021-06-03 | 7,927 | $21.92 | $173.8K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-05-24 | 2021-06-03 | 7,927 | $4.23 | $33.5K | 7,927 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise deriv | 2021-05-17 | 2021-05-19 | 7,926 | — | $0 | 118,904 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-05-17 | 2021-05-19 | 90 | $26.01 | $2.3K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | M Exercise | 2021-05-17 | 2021-05-19 | 7,926 | $4.23 | $33.5K | 7,926 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-05-17 | 2021-05-19 | 5,807 | $24.41 | $141.7K | 2,119 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-05-17 | 2021-05-19 | 2,029 | $25.43 | $51.6K | 90 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 45,000 | — | $0 | 45,000 | SEC↗ |